Coordinated project aims to increase deal-flow and secure more formal agreements with international companies.
Uppsala BIO runs the project Innovation Platform for Industrial and Investor Partnership Life Science (3i) in Eastern Sweden, together with SLU Holding, UIC, UU Innovation, Inkubera Örebro, Create Business Incubator Västerås and Linköping University. A coordinated approach is being developed to increase deal-flow so that more value-creating collaborations with major international companies can be created. During 2017, Uppsala BIO has had one formal agreement with a large company (GE Healthcare Life Sciences). In addition, a larger number of more informal relationships with global companies are maintained on a regular basis. Discussions about agreements with further international companies are currently underway.
Financing: Uppsala BIO*, ERUF. Project 3i (Project ID 20200636)
Project duration: 2016–2018
Contact: Magnus Engevik, Uppsala BIO
Uppsala BIO’s role: Project leadership
* Uppsala BIO’s core funding comes from the regional financiers Region Uppsala, SLU, Uppsala University and Uppsala Municipality, as well as from VINNVÄXT, a Vinnova-funded initiative.
Magnus Engevik, M.Sc., Business Development: “I want to contribute to delivering tomorrow’s solutions to today’s life science problems. Faster, easier and cheaper. And with better results than today.”